CompletedPhase 4

The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

Malaysia110 participantsStarted 2019-12-01

Plain-language summary

This study compares the duration of active phase of labour in women who received buscopan and those who don't.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primigravida * Vertex presentation * Term gestation (37-41w) * Active phase of labor (4cm with regular contraction at least 2:10) * Spontaneous labor * Oxytocin augmentation * Maternal height ≥150cm Exclusion Criteria: * Multiple pregnancies * Previous uterine surgery * Hypertensive disease in pregnancy * Gestational diabetes on treatment * Clinical estimation of fetal weight \>3.8kg * Induction of labor * Meconium stained liquor * Allergy to hyoscine * Medical contraindication to hyoscine (i.e Myasthenia gravis, glaucoma, megacolon)

What they're measuring

Labor length

Timeframe: Through study completion until delivery up to 12 hours

Trial details

NCT IDNCT04349722

SponsorNational University of Malaysia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-06-30

View on ClinicalTrials.gov More Labor Long trials